• 1
    Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C 2006 Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259: 598605.
  • 2
    Farhat GN, Strotmeyer ES, Newman AB, Sutton-Tyrrell K, Bauer DC, Harris T, Johnson KC, Taaffe DR, Cauley JA 2006 Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: The health, aging, and body composition study. Calcif Tissue Int 79: 102111.
  • 3
    Magnus JH, Broussard DL 2005 Relationship between bone mineral density and myocardial infarction in US adults. Osteoporos Int 16: 20532062.
  • 4
    Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR 2005 Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20: 19121920.
  • 5
    Alagiakrishnan K, Juby A, Hanley D, Tymchak W, Sclater A 2003 Role of vascular factors in osteoporosis. J Gerontol A Biol Sci Med Sci 58: 362366.
  • 6
    Horiuchi N, Maeda T 2006 Statins and bone metabolism. Oral Dis 12: 85101.
  • 7
    Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H 2000 HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283: 32053210.
  • 8
    Schoofs MW, Sturkenboom MC, van der Klift M, Hofman A, Pols HA, Stricker BH 2004 HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res 19: 15251530.
  • 9
    Wang PS, Solomon DH, Mogun H, Avorn J 2000 HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283: 32113216.
  • 10
    Lacroix AZ, Cauley JA, Pettinger M, Hsia J, Bauer DC, McGowan J, Chen Z, Lewis CE, McNeeley SG, Passaro MD, Jackson RD 2003 Statin use, clinical fracture, and bone density in postmenopausal women: Results from the Women's Health Initiative Observational Study. Ann Intern Med 139: 97104.
  • 11
    Pedersen TR, Kjekshus J 2000 Statin drugs and the risk of fracture. 4S Study Group. JAMA 284: 19211922.
  • 12
    Reid IR, Hague W, Emberson J, Baker J, Tonkin A, Hunt D, MacMahon S, Sharpe N 2001 Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. Lancet 357: 509512.
  • 13
    Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tanko LB 2007 Links between cardiovascular disease and osteoporosis in postmenopausal women: Serum lipids or atherosclerosis per se ? Osteoporos Int 18: 505512.
  • 14
    Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, Battaglia E 2004 Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 74: 136142.
  • 15
    D'Amelio P, Pescarmona GP, Gariboldi A, Isaia GC 2001 High density lipoproteins (HDL) in women with postmenopausal osteoporosis: A preliminary study. Menopause 8: 429432.
  • 16
    Lidfeldt J, Holmdahl L, Samsioe G, Nerbrand C, Nyberg P, Schersten B, Agardh CD 2002 The influence of hormonal status and features of the metabolic syndrome on bone density: A population-based study of Swedish women aged 50 to 59 years. The women's health in the Lund area study. Metabolism 51: 267270.
  • 17
    Solomon DH, Avorn J, Canning CF, Wang PS 2005 Lipid levels and bone mineral density. Am J Med 118: 1414.
  • 18
    Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K 2002 Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49: 211217.
  • 19
    Zabaglia SF, Pedro AO, Pinto Neto AM, Guarisi T, Paiva LH, Lane E 1998 [An exploratory study of the association between lipid profile and bone mineral density in menopausal women in a Campinas reference hospital]. Cad Saude Publica 14: 779786.
  • 20
    Adami S, Braga V, Gatti D 2001 Association between bone mineral density and serum lipids in men. JAMA 286: 791792.
  • 21
    Deeg D, Knipscheer C, van Tilburg W 1993 Autonomy and Well-Being in the Aging Population. Concepts and Design of the Longitudinal Aging Study Amsterdam. Institute of Gerontology, Bunnink, The Netherlands.
  • 22
    Sigurdsson G, Aspelund T, Chang M, Jonsdottir B, Sigurdsson S, Eiriksdottir G, Gudmundsson A, Harris TB, Gudnason V, Lang TF 2006 Increasing sex difference in bone strength in old age: The Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK). Bone 39: 644651.
  • 23
    Dennison EM, Syddall HE, Aihie SA, Martin HJ, Cooper C 2007 Lipid profile, obesity and bone mineral density: The Hertfordshire Cohort Study. QJM 100: 297303.
  • 24
    Gerdhem P, Isaksson A, Akesson K, Obrant KJ 2005 Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16: 15061512.
  • 25
    Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V, Joakimsen RM 2006 Features of the metabolic syndrome and the risk of non-vertebral fractures: The Tromso study. Osteoporos Int 17: 426432.
  • 26
    Vestergaard P 2007 Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18: 427444.
  • 27
    Pérez-Castrillón JL, De Luis D, Martín-Escudero JC, Asensio T, del Amo R, Izaola O 2004 Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complications 18: 317321.
  • 28
    Chapman MJ 2006 Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease. Pharmacol Ther 111: 893908.
  • 29
    Birjmohun RS, van der Steeg WA, Stroes ES, Kastelein JJ 2006 [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations]. Ned Tijdschr Geneeskd 150: 22452250.
  • 30
    Noor R, Shuaib U, Wang CX, Todd K, Ghani U, Schwindt B, Shuaib A 2007 High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 192: 9299.
  • 31
    Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL 1999 Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14: 20672078.
  • 32
    Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, Parhami F 2004 Oxysterols regulate differentiation of mesenchymal stem cells: Pro-bone and anti-fat. J Bone Miner Res 19: 830840.
    Direct Link:
  • 33
    Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680687.
  • 34
    Parhami F, Mody N, Gharavi N, Ballard AJ, Tintut Y, Demer LL 2002 Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J Bone Miner Res 17: 19972003.
  • 35
    Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, Vaccarino V, Zhang Y, Kiel DP 2004 Long-term effects of serum cholesterol on bone mineral density in women and men: The Framingham Osteoporosis Study. Bone 34: 557561.
  • 36
    Brownbill RA, Ilich JZ 2006 Lipid profile and bone paradox: Higher serum lipids are associated with higher bone mineral density in postmenopausal women. J Womens Health (Larchmt) 15: 261270.
  • 37
    Tanko LB, Bagger YZ, Nielsen SB, Christiansen C 2003 Does serum cholesterol contribute to vertebral bone loss in postmenopausal women ? Bone 32: 814.
  • 38
    Rejnmark L, Vestergaard P, Mosekilde L 2006 Statin but not non-statin lipid-lowering drugs decrease fracture risk: A nation-wide case-control study. Calcif Tissue Int 79: 2736.
  • 39
    Kuchuk NO, van Schoor NM, Pluijm SMF, Smit JH, de Ronde W, Lips P 2007 The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women. Clin Endocrinol (Oxf) 67: 295303.
  • 40
    Wu FC, von Eckardstein A 2003 Androgens and coronary artery disease. Endocr Rev 24: 183217.
  • 41
    van Schoor NM, Visser M, Pluijm SM, Kuchuk N, Smit JH, Lips P 2008 Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 42: 260266.
  • 42
    Melamed ML, Muntner P, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P 2008 Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: Results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 28: 11791185.